Variant report
Variant | nsv519391 |
---|---|
Chromosome Location | chr6:161812626-161814907 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:3)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
(count:3 , 50 per page) page:
1
No data |
No data |
No data |
No data |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs11964284 | chr6:161812626-161812627 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
2 | rs552221271 | chr6:161812676-161812677 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
3 | rs148595059 | chr6:161812721-161812722 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
4 | rs11967026 | chr6:161812728-161812729 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
5 | rs182659961 | chr6:161812779-161812780 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
6 | rs142786879 | chr6:161812848-161812849 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
7 | rs185370725 | chr6:161812849-161812850 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
8 | rs534541541 | chr6:161812906-161812907 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
9 | rs147258109 | chr6:161812915-161812916 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
10 | rs10455880 | chr6:161812932-161812933 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | mRNA abundance |
11 | rs539669661 | chr6:161812969-161812970 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
12 | rs10455881 | chr6:161813005-161813006 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
13 | rs576484849 | chr6:161813037-161813038 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
14 | rs542202912 | chr6:161813043-161813044 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
15 | rs531944241 | chr6:161813101-161813102 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
16 | rs190678285 | chr6:161813132-161813133 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
17 | rs572116190 | chr6:161813139-161813140 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
18 | rs182845590 | chr6:161813142-161813143 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
19 | rs10455882 | chr6:161813159-161813160 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
20 | rs560037987 | chr6:161813191-161813192 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
21 | rs10455883 | chr6:161813195-161813196 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
22 | rs552122237 | chr6:161813204-161813205 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
23 | rs10455884 | chr6:161813210-161813211 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
24 | rs531354884 | chr6:161813220-161813221 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
25 | rs375862714 | chr6:161813246-161813247 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
26 | rs200298473 | chr6:161813262-161813263 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
27 | rs112304578 | chr6:161813347-161813348 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
28 | rs144683431 | chr6:161813369-161813370 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
29 | rs189084249 | chr6:161813377-161813378 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
30 | rs10945747 | chr6:161813394-161813395 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
31 | rs202036026 | chr6:161813416-161813417 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
32 | rs148241377 | chr6:161813536-161813537 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
33 | rs150905751 | chr6:161813537-161813538 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
34 | rs67425763 | chr6:161813558-161813559 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
35 | rs536588095 | chr6:161813565-161813566 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
36 | rs571193696 | chr6:161813567-161813568 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
37 | rs199873875 | chr6:161813576-161813577 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
38 | rs539999156 | chr6:161813605-161813606 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
39 | rs193007390 | chr6:161813661-161813662 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
40 | rs556190993 | chr6:161813664-161813665 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
41 | rs535536733 | chr6:161813709-161813710 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
42 | rs140815594 | chr6:161813738-161813739 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
43 | rs572079746 | chr6:161813771-161813772 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
44 | rs372052314 | chr6:161813803-161813804 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
45 | rs67799063 | chr6:161813804-161813805 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
46 | rs397723896 | chr6:161813814-161813815 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
47 | rs374900642 | chr6:161813815-161813816 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
48 | rs541042633 | chr6:161813819-161813820 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
49 | rs182936138 | chr6:161813846-161813847 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
50 | rs577092512 | chr6:161813847-161813848 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Uveal melanoma | 21693616 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Biliary cancer | 19435499 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Malaria | 21533027 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Ewing''s sarcoma | 17952124 | CNVD |
Biliary cancer | 20360734 | CNVD |
Breast cancer | 20360734 | CNVD |
Coronary artery disease | 20360734 | CNVD |
Crohn''s disease | 20360734 | CNVD |
Hypertension | 20360734 | CNVD |
Rheumatoid arthritis | 20360734 | CNVD |
Type 1 diabetes | 20360734 | CNVD |
Type 2 diabetes | 20360734 | CNVD |
Acute lymphoblastic leukemia | 22237106 | CNVD |
Neuroblastoma | 18923191 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Melanoma | 18172304 | CNVD |
Cancer | 21637783 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Follicular lymphoma | 19010834 | CNVD |
Non-small cell lung cancer | 21044232 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Breast cancer | 21264507 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Glioblastoma multiforme | 19960244 | CNVD |
Hepatocellular carcinoma | 22174799 | CNVD |
Phyllodes tumor | 17334353 | CNVD |
Breast cancer | 16608533 | CNVD |
Non-small cell lung cancer | 21385341 | CNVD |
Prostate cancer | 16705090 | CNVD |
Adenoid cystic carcinoma | 17372589 | CNVD |
Colorectal cancer | 16272173 | CNVD |
Ependymoma | 16718352 | CNVD |
Gastric cancer | 17908304 | CNVD |
High-proliferative meningiomas | 17937814 | CNVD |
Intracranial tumor | 16823260 | CNVD |
Monoclonal gammopathy of undetermined significance | 17077331 | CNVD |
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Breast cancer | 16272173 | CNVD |
Wilms tumour | 21544195 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Congenital diaphragmatic hernia | 21085971 | CNVD |
Malignant melanoma | 18718029 | CNVD |
Acute lymphoblastic leukemia | 17690704 | CNVD |
Breast cancer | 21858162 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Breast cancer | 17603634 | CNVD |
Developmental delay | 19490664 | CNVD |
Burkitt''s lymphoma | 18698080 | CNVD |
Neurodevelopmental disorder | 22521361 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Adenoid cystic carcinoma | 18698036 | CNVD |
head and neck squamous cell carcinoma | 17671120 | CNVD |
Leukemia | 18688285 | CNVD |
Renal cell carcinoma | 18592004 | CNVD |
T-cell prolymphocytic leukemia | 17713554 | CNVD |
Prostate cancer | 18632612 | CNVD |
Lung cancer | 18438408 | CNVD |
Burkitt''s lymphoma | 19759907 | CNVD |
Esophageal cancer | 21851588 | CNVD |
T-cell acute lymphoblastic leukemia | 18185524 | CNVD |
Breast cancer | 17133270 | CNVD |
Testicular germ cell tumor | 18059402 | CNVD |
Developmental delay | 21147756 | CNVD |
Chordoma | 18071362 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Autism | 22241247 | CNVD |
Breast cancer | 16397240 | CNVD |
Atherosclerosis | 21956041 | CNVD |
Maculopathy | 20981449 | CNVD |
Retinoblastoma | 22278416 | CNVD |
Primary central nervous system lymphoma | 21088137 | CNVD |
Ovarian cancer | 20844748 | CNVD |
Uveal melanoma | 20484589 | CNVD |
Glioblastoma multiforme | 19435819 | CNVD |
Astrocytoma | 16205629 | CNVD |
Parkinson disease | 17160897 | CNVD |
Cancer | 20164920 | CNVD |
Breast cancer | 22522925 | CNVD |
Schizophrenia | 20838587 | CNVD |
Early-onset parkinson disease | 21993715 | CNVD |
Glioblastoma | 18772890 | CNVD |
Pancreatic cancer | 20981101 | CNVD |
Autism | 21360662 | CNVD |
Melanoma | 20877625 | CNVD |
Pancreatic cancer | 17952125 | CNVD |
Intellectual disability | 22102821 | CNVD |
Parkinson disease | 0 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr6:161780600-161835800 | Weak transcription | Right Atrium | heart |
2 | chr6:161797600-161815000 | Weak transcription | Fetal Lung | lung |
3 | chr6:161811000-161815400 | Weak transcription | H1 Derived Neuronal Progenitor Cultured Cells | ES cell derived |
4 | chr6:161811200-161814600 | Weak transcription | Ganglion Eminence derived primary cultured neurospheres | brain |
5 | chr6:161811200-161815000 | Weak transcription | ES-I3 Cell Line | embryonic stem cell |
6 | chr6:161811400-161814400 | Weak transcription | H9 Derived Neuron Cultured Cells | ES cell derived |
7 | chr6:161814400-161815000 | Enhancers | H9 Derived Neuron Cultured Cells | ES cell derived |
8 | chr6:161814400-161815600 | Enhancers | Psoas Muscle | Psoas |
9 | chr6:161814400-161817800 | Enhancers | Skeletal Muscle Female | skeletal muscle |
10 | chr6:161814600-161815000 | Enhancers | H9 Derived Neuronal Progenitor Cultured Cells | ES cell derived |
11 | chr6:161814600-161815600 | Enhancers | Ganglion Eminence derived primary cultured neurospheres | brain |
12 | chr6:161814800-161817800 | Enhancers | Brain Germinal Matrix | brain |